Frontline Ph-negative B-cell precursor acute lymphoblastic leukemia treatment and the emerging role of blinatumomab

Frontline Ph-negative B-cell precursor acute lymphoblastic leukemia treatment and the emerging role of blinatumomab

Abstract This narrative review seeks to summarize chemotherapeutic regimens commonly used for patients with newly diagnosed Philadelphia (Ph) chromosome–negative B-cell precursor acute lymphoblastic leukemia (BCP-ALL) in the frontline setting and to describe the latest clinical research using the bi...

Full description

Saved in:

Bibliographic Details
Main Authors:	Elias J. Jabbour, Hagop M. Kantarjian, Nicola Goekbuget, Bijal D. Shah, Sabina Chiaretti, Jae H. Park, Anita W. Rijneveld, Lia Gore, Shaun Fleming, Aaron C. Logan, Josep M. Ribera, Tobias F. Menne, Khalid Mezzi, Faraz Zaman, Kelly Velasco, Nicolas Boissel
Format:	Article
Language:	English
Published:	Nature Publishing Group 2024-11-01
Series:	Blood Cancer Journal
Online Access:	https://doi.org/10.1038/s41408-024-01179-4
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Molecular characterization and predictors of relapse in patients with Ph + ALL after frontline ponatinib and blinatumomab
by: Nicholas J. Short, et al.
Published: (2025-05-01)

Blinatumomab in pediatric B-acute lymphoblastic leukemia
by: Yifang Cheng, et al.
Published: (2025-07-01)

T-cell dysfunction during blinatumomab therapy in pediatric acute lymphoblastic leukemia
by: Julie Ma, et al.
Published: (2025-08-01)

Blinatumomab in the Treatment of Acute Lymphoblastic Leukemia: Russian Multicenter Clinical Trial
by: SN Bondarenko, et al.
Published: (2019-03-01)

Reduced-dose chemotherapy followed by blinatumomab for newly diagnosed philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia: a propensity-matched comparison with hyper-CVAD
by: Jing Lu, et al.
Published: (2025-02-01)

Leukemia Burden Impacts the Efficacy and Toxicity of Blinatumomab in Pediatric B‐Cell Acute Lymphoblastic Leukemia
by: Weiling Yan, et al.
Published: (2025-08-01)

Lower-intensity chemo-immunotherapy with cladribine, low-dose cytarabine, venetoclax and blinatumomab produces high response rates in patients with <i>BCR::ABL1</i>-negative B-cell / myeloid mixed phenotype acute leukemia
by: Roberta S. Azevedo, et al.
Published: (2025-06-01)

The combination of a tyrosine kinase inhibitor and blinatumomab in patients with Philadelphia chromosome–positive acute lymphoblastic leukemia or Philadelphia chromosome‐like acute lymphoblastic leukemia
by: Xiaoxia Wu, et al.
Published: (2024-09-01)

Update on long-term outcomes of a cohort of patients with TCF3::HLF positive acute lymphoblastic leukemia treated with blinatumomab and stem cell transplantation
by: Aida Zeckanovic, et al.
Published: (2025-02-01)

Efficacy and safety comparison of CAR-T and blinatumomab immunotherapy as bridge-to-transplant strategies in relapsed/refractory B cell acute lymphoblastic leukemia
by: Wenyue Cao, et al.
Published: (2025-04-01)

Efficacy and safety of blinatumomab in Chinese patients with relapsed/refractory B-cell acute lymphoblastic leukemia: a single-center retrospective study
by: Yan Wang, et al.
Published: (2025-05-01)

BLINATUMOMAB IN THE THERAPY OF ACUTE B-LYMPHOID LEUKEMIA
by: Ugo Testa, et al.
Published: (2024-08-01)

Relapsed Philadelphia chromosome‐positive B‐cell acute lymphoblastic leukaemia responds well to a combination of modified hyper‐CVAD, blinatumomab and tyrosine kinase inhibitor
by: Gaétan Basile, et al.
Published: (2025-02-01)

Chromatin accessibility landscape of pediatric T‐lymphoblastic leukemia and human T‐cell precursors
by: Büşra Erarslan‐Uysal, et al.
Published: (2020-08-01)

Blinatumomab use in pediatric B-ALL: where are we now?
by: Anurekha G. Hall, et al.
Published: (2025-08-01)

INFECTIOUS RISKS AND COMPLICATIONS IN ADULT LEUKEMIC PATIENTS RECEIVING BLINATUMOMAB
by: Wonhee So, et al.
Published: (2018-05-01)

Post-transplant maintenance with blinatumomab for children, adolescents, and young adults with relapsed and refractory B-cell acute lymphoblastic leukemia: results of phase I in SCT-ALL-BLIN21
by: Hirotoshi Sakaguchi, et al.
Published: (2025-07-01)

Novel outpatient infusion model of blinatumomab: case studies of two patients
by: LI Guijun, et al.
Published: (2025-04-01)

A rare case of precursor B-cell lymphoblastic lymphoma of the orbit in a child
by: Ruhi Girish Jange, et al.
Published: (2025-05-01)

Leukemia-associated immunophenotype of tumor cells in childhood B-precursors acute lymphoblastic leukemia
by: L. V. Movchan
Published: (2014-07-01)

CD-19-directed immunotherapy resistance mechanisms of B-precursor acute lymphoblastic leukemia
by: E. V. Glukhanyuk, et al.
Published: (2019-01-01)

Precursor B Cell Acute Lymphoblastic Leukemia Presenting with Repeated Episodes of Hemophagocytic Lymphohistiocytosis
by: Nihar Desai, et al.

Benchmarking miRNA reference genes in B-cell precursor acute lymphoblastic leukemia
by: Teresa Mack, et al.
Published: (2024-11-01)

Synchronous childhood T-lymphoblastic lymphoma and B-cell precursor acute lymphoblastic leukemia associated with constitutional MMR deficiency syndrome –a case report
by: Joanna Bulsa, et al.
Published: (2025-05-01)

Adverse events in the nervous system associated with blinatumomab: a real-world study
by: Wen Gao, et al.
Published: (2025-02-01)

Successful Use of Extracorporeal Membrane Oxygenation for Respiratory Failure Caused by Mediastinal Precursor T Lymphoblastic Lymphoma
by: Masafumi Oto, et al.
Published: (2014-01-01)

Precursor B-cell lymphoblastic lymphoma of bone in children: A close mimicker of Ewing's sarcoma
by: Shwetha Seetharam, et al.
Published: (2018-01-01)

Immunotherapy- (Blinatumomab-) Related Lineage Switch of KMT2A/AFF1 Rearranged B-Lymphoblastic Leukemia into Acute Myeloid Leukemia/Myeloid Sarcoma and Subsequently into B/Myeloid Mixed Phenotype Acute Leukemia
by: Rui R. He, et al.
Published: (2019-01-01)

Ponatinib/blinatumomab for relapsed Philadelphia chromosome-positive leukemia as a bridge to allogeneic transplantation
by: Yasutaka Sadaga, et al.
Published: (2025-12-01)

IKZF1 DELETIONS ARE INDEPENDENT PROGNOSTIC FACTOR IN PEDIATRIC B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA
by: G. A. Tsaur, et al.
Published: (2017-01-01)

Diagnosis of Acute Lymphoblastic Leukemia Originating From T-Lineage Precursors and Approaches to Minimal Residual Disease Monitoring
by: OA Chernysheva, et al.
Published: (2018-12-01)

Multicolor flow cytometry immunophenotyping and characterization of aneuploidy in pediatric B-cell precursor acute lymphoblastic leukemia
by: Magdalena Pierzyna-Świtała, et al.
Published: (2021-10-01)

BCL2 inhibition in adult acute lymphoblastic leukemia: ready for primetime?
by: Nitin Jain, et al.
Published: (2025-02-01)

Family doctors on the frontline
by: Bob Mash
Published: (2020-05-01)

Characterization of Immunoglobulin Heavy Locus Rearrangements in Molecular Subtypes of Childhood B‐Cell Precursor Acute Lymphoblastic Leukemia
by: Guilherme Navarro Nilo Giusti, et al.
Published: (2025-04-01)

Blinatumomab and better BCR::ABL1 inhibition begets better bone marrow transplant outcomes
by: Marlise R. Luskin, et al.
Published: (2025-06-01)

Utility of a Large Series of B‐Cell Precursor Acute Lymphoblastic Leukemia Cell Lines as a Model System
by: Minori Tamai, et al.
Published: (2025-03-01)

The system in operation. Frontline news
by: Monika Bogdanowska
Published: (2024-07-01)

A novel translocation: t(2;14)(p12;q32) in a case of precursor B-acute lymphoblastic leukemia
by: Prasannakumari Sampathkumar, et al.
Published: (2017-01-01)

Myelodysplastic Syndrome with Myelofibrosis Transformed to a Precursor B-Cell Acute Lymphoblastic Leukemia: A Case Report with Review of the Literature
by: Ayed A. Algarni, et al.
Published: (2012-01-01)